Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors
New capabilities and simple, standard site experience cut trial time and expense Fixed price implementation to get up and running quickly Industry advances to connected trials asseven of the top 20 biopharmas adopt Veeva Site Connect SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ — Veeva Syst
Northstar Financial Services (Bermuda) Investors Who Suffered Losses May Be Able To Sue Their Brokers
Our Annuity Fraud Lawyers Are Representing Asian and Latin American Nationals HOUSTON, Sept. 9, 2024 /PRNewswire/ — Shepherd Smith Edwards and Kantas (investorlawyers.com) is continuing to investigate Northstar Financial Service (Bermuda). Many of the investors who suffered losses are foreig
Eisai to Present E7386, co-created by PRISM BioLab and Eisai, at the ESMO (European Society for Medical Oncology) Annual Meeting
Abstract Released for E7386, Created Through Collaborative Research Between Eisai and PRISM TOKYO, Sept. 8, 2024 /PRNewswire/ — PRISM BioLab, Co. Ltd. (“PRISM”), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein intera
Media Advisory – Deputy Prime Minister’s itinerary for Monday, September 9, 2024
OTTAWA, ON, Sept. 8, 2024 /CNW/ – Note: All times local. Nanaimo, British Columbia The Deputy Prime Minister will attend regional Caucus meetings. Closed to media. This document is also available at https://deputypm.canada.ca/en SOURCE Deputy Prime Minister’s Office
ESMO 2024 | Ascentage Pharma to Present Updated Data of Olverembatinib in Patients with SDH-Deficient GIST during a Mini Oral Presentation at the 2024 ESMO Congress
ROCKVILLE, Md. and SUZHOU, China, Sept. 9, 2024 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for malignancies, today announced that it will present the lates
ALIMENTATION COUCHE-TARD COMMENTS ON SEVEN & I HOLDINGS’ RESPONSE NOT TO ENGAGE IN FRIENDLY DISCUSSIONS REGARDING A VALUE CREATING COMBINATION
LAVAL, QC, Sept. 8, 2024 /PRNewswire/ – Alimentation Couche-Tard Inc. (“Couche-Tard” or the “Corporation”) (TSX: ATD), a global leader in convenience and mobility, today issued the following statement regarding the response letter sent by the Board of Directors of Seven
Guideline Launches First Cross-Media Ad Spend Visibility into China
Advertisers, Media Now Able to Track Chinese Ad Demand with Guideline SYDNEY, Sept. 9, 2024 /PRNewswire/ — Guideline, the world’s leading provider of advertising intelligence and media planning solutions, has today delivered the first cross-media visibility into Chinese media expenditu
Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors
New capabilities and simple, standard site experience cut trial time and expenseFixed price implementation to get up and running quicklyIndustry advances to connected trials as seven of the top 20 biopharmas adopt Veeva Site Connect SYDNEY, Sept. 9, 2024 /PRNewswire/ — Veeva Systems (NYSE: V
SDAIA to Unveil Key AI Strategies and International Collaborations at Global AI Summit Press Conference
RIYADH, Saudi Arabia, Sept. 9, 2024 /PRNewswire/ — The Saudi Authority for Data and Artificial Intelligence (SDAIA) will hold a press conference on Sunday, September 8, at the King Abdulaziz International Conference Center. The press conference will highlight key aspects of the upcoming third
Saudi Arabia’s landmark Global AI Summit to address harnessing AI for the good of humanity
RIYADH, Saudi Arabia, Sept. 8, 2024 /PRNewswire/ — Ahead of the Global AI Summit (GAIN) this week, H.E. Dr. Abdullah bin Sharaf Alghamdi, Chairman of the Saudi Data and AI Authority (SDAIA), gave a preview of Saudi Arabia’s landmark AI event, which will address the Now, Next and Never f
